The interplay of fibroblast growth factor (FGF) and nodal signaling in the Xenopus gastrula marginal zone specifies distinct populations of presumptive mesodermal cells. Cells in the vegetal marginal zone, making up the presumptive leading edge mesoderm, are exposed to nodal signaling, as evidenced by SMAD2 activation, but do not appear to be exposed to FGF signaling, as evidenced by the lack of MAP kinase (MAPK) activation. However, in the animal marginal zone, activation of both SMAD2 and MAPK occurs. The differential activation of these two signaling pathways in the marginal zone results in the vegetal and animal marginal zones expressing different genes at gastrulation, and subsequently having different fates, with the vegetal marginal zone contributing to ventral mesoderm (e.g. ventral blood island) and the animal marginal zone giving rise to dorsal fates (e.g. notochord and somite). We report here the cloning of a cDNA encoding a novel nuclear protein, Xmenf, that is expressed in the vegetal marginal zone. The expression of Xmenf is induced by nodal signaling and negatively regulated by FGF signaling. Results from animal cap studies indicate that Xmenf plays a role in the pathway of ventral mesoderm induction in the vegetal marginal zone. q
Introduction
Members of the fibroblast growth factor (FGF) family of secreted signaling molecules are implicated in a variety of developmental processes. At early stages of vertebrate embryogenesis, FGF signaling has been shown to be involved in mesoderm formation (Amaya et al., 1991; Rodaway et al., 1999; Yamaguchi et al., 1994) , as well as in induction and posteriorization of the neuroectoderm (Holowacz and Sokol, 1999; Lamb and Harland, 1995; Launay et al., 1996) . At later stages, FGF signaling is required for various aspects of organogenesis, including the growth and patterning of the brain (Rhinn and Brand, 2001) , the initiation and outgrowth of the limb buds (Capdevila and Izpisua Belmonte, 2001) , somite boundary formation (Dubrulle et al., 2001; Sawada et al., 2001) , tooth morphogenesis (Thesleff and Sharpe, 1997) , and the outgrowth and branching of the respiratory system (Metzger and Krasnow, 1999) . While FGF acts as a primary inducer in many cases, it has also been shown to act as a competence factor. Examples of the competence-inducing activity of FGF include chick limb bud formation (Laufer et al., 1994) , Xenopus mesoderm induction (Cornell et al., 1995) , chick neural induction (Streit et al., 2000; Wilson et al., 2000) , and ascidian notochord induction (Darras and Nishida, 2001) . In Xenopus mesoderm induction (Cornell et al., 1995) , it is proposed that a maternal FGF at the equator of the embryo permits cells to respond to activin-like mesoderm-inducing signals. Acquisition of competence is an important developmental step that contributes to the diversity of cell types formed in the early embryo using a relatively small number of inducing molecules. Signal transduction mechanisms leading to induction, from ligand-receptor interactions to intracellular transduction of signals into the nucleus, have been extensively studied. However, molecular mechanisms of competence, such as how competence factors interact with other signaling pathways, are less well understood.
The Xenopus animal cap assay has long been used to study embryonic inducing factors. Members of the activin and nodal families, which signal through a common pathway involving the activation of SMAD2 (Baker and Harland, 1996; Chen et al., 1996; Graff et al., 1996; Massague, 1998; Nomura and Li, 1998; Whitman, 2001; Whitman, 1998) , induce dorsal-type mesoderm (muscle and notochord) in animal caps. Endogenous FGF in the animal cap is an essential competence factor for the induction of dorsal mesoderm (Cornell and Kimelman, 1994; Cornell et al., 1995; Kumano et al., 2001; LaBonne and Whitman, 1994) . The act of dissecting animal cap ectoderm from blastula embryos activates FGF expression, presumably as a wounding response, and elevated MAP kinase (MAPK) activation can be detected in dissected animal caps (LaBonne and Whitman, 1997) . While the level of MAPK activation (actMAPK) in animal caps is not sufficient to divert them from their default state of differentiation as ectoderm, inhibition of endogenous FGF signaling with a dominant negative FGF receptor (XFD) dramatically alters how animal caps respond to the Xenopus nodal-related factor Xnr2 (Kumano et al., 2001) . Injection of Xnr2 RNA alone into the animal cap resulted in strong induction of muscle actin, while co-injection of Xnr2 and XFD completely suppressed muscle actin expression, and instead strong expression of a T3 globin, a ventral mesoderm-specific gene, was observed. This result was not simply a quantitative response to mesoderm induction because equal amounts of the pan-mesodermal gene eomesodermin (eomes; were induced in both sets of animal caps. These results not only impact the interpretation of animal cap assay results in general, but they also point to a new pathway of ventral mesoderm induction.
Furthermore, recent results regarding the activation of the SMAD2 and MAPK pathways in gastrula stage Xenopus embryos suggest that this modulation of nodal signaling by FGF may be important in the endogenous pathway of ventral mesoderm induction (Christen and Slack, 1999; Curran and Grainger, 2000; Kumano et al., 2001; Lee et al., 2001) . SMAD2 is activated broadly in the marginal zone of the Xenopus gastrula embryo, while actMAPK is restricted along the animal/vegetal axis of the marginal zone. The vegetal part of the marginal zone, comprising those cells nearest to the blastopore and which constitutes the leading edge mesoderm, has no, or very little, activated MAPK, whereas the cells in the marginal zone closer to the animal pole stain strongly with an antibody to activated MAPK. Fate mapping has shown that the leading edge mesoderm is the primary contributor to the ventral blood islands (Lane and Smith, 1999) . Thus, in the presumptive ventral blood islands of the gastrula embryo, there is a convergence of low actMAPK and high SMAD2 signaling. Inhibition of FGF signaling in the gastrula marginal zone with XFD leads to an expansion of globin-expressing cells at tadpole stages, with a concomitant loss of muscle actinexpressing cells, whereas injection of FGF into the vegetal marginal zone results in a complete loss of globin-expressing cells (Kumano and Smith, 2000) . Taken together, these results point to a role for endogenous FGF signaling in modulating the response of cells to nodal induction in the gastrula embryo.
We describe here the use of a subtractive approach to isolate genes that are differentially activated by nodal signaling in the presence versus the absence of FGF signaling. We present the results for one such novel gene, Xmenf, that is expressed in the vegetal marginal zone by the combined actions of high nodal and low FGF signaling. The predicted amino acid sequence of Xmenf has no recognizable protein motifs, although it appears to be nuclear localized. Results from animal cap studies implicate Xmenf in ventral mesoderm induction by nodal/activin signaling, but not in dorsal mesoderm induction. In this article, the term 'ventral mesoderm' will be used to refer to the tissue that resides in the ventral region of the tadpole, such as the ventral blood islands, and to tissues in early stage embryos that will give rise to ventral mesoderm. Our use of the term 'ventral mesoderm' in the gastrula embryo should not be confused with 'ventral marginal zone', which is the region of the marginal zone directly opposite to the Spemann organizer. While some ventral mesoderm does arise from the ventral marginal zone, the progenitors of the ventral mesoderm are much more widely distributed in the gastrula embryo (Ciau-Uitz et al., 2000; Lane and Smith, 1999; Mills et al, 1999; Tracey et al., 1998) . In addition, the ventral marginal zone also gives rise to posterior somites, and thus does not give rise exclusively to ventral mesoderm (Dale and Slack, 1987; Lane and Smith, 1999; Moody, 1987) .
Results

Xmenf is a novel target gene of nodal signaling that is negatively regulated by FGF signaling
The Xenopus nodal-related gene Xnr2 is a strong inducer of dorsal mesoderm when injected as RNA into Xenopus animal caps. We have recently shown that this dorsal mesoderm inducing activity is the product of the combined activities of exogenous nodal and endogenous FGF signaling (Kumano et al., 2001) . When Xnr2 RNA was coinjected with RNA for dominant negative FGF receptor (XFD), a ventral mesoderm marker (globin) was induced rather than a dorsal mesoderm marker (muscle actin).
To better understand the molecular mechanisms of how the nodal inductive pathway differs in the presence versus the absence of FGF signaling, we undertook isolation of nodal target genes induced in the absence of FGF signaling. We used a subtractive approach to isolate genes that were induced in animal caps injected with Xnr2 and XFD RNAs, but not induced in those injected with XFD RNA alone (Fig.  1A) . Xenopus embryos at the 2-cell stage were injected in the animal poles with XFD plus Xnr2 or XFD plus frameshifted Xnr2 (fsXnr2) RNAs. Animal caps were dissected at stages 8-9 and cultured until stage 10.5 when RNA was extracted from the two groups of animal caps. Subtractive hybridization was performed between RNAs pooled from the two groups of caps, and suppression polymerase chain reaction (PCR) (Hubank and Schatz, 1994) was used to construct a cDNA library enriched for nodal-induced genes. In a preliminary screen, one 710 bp clone was found differentially expressed in animal caps injected with Xnr2 1 XFD versus fsXnr2 1 XFD (Fig. 1B) . Screening a gastrula cDNA library using this clone as a probe yielded a 2.1 kb clone that contained a poly A tail and the last 551 bp of the 710 bp subtraction clone at the 5 0 end. A full-length cDNA, which was estimated to be 3.2 kb by northern blotting (Fig. 1B) , was constructed by isolating a 1.4 kb fragment containing a translation start site and 101 bp of 5 0 UTR with 5 0 RACE, and both strands of the composite full-length cDNA were sequenced. This clone, which we designate as Xmenf (Xenopus mesendoderm nuclear factor), has 3120 bp and encodes a predicted 756 amino acid polypeptide ( Fig. 2A) . The predicted amino acid sequence of the protein shows no homology to any known proteins other than the predicted protein encoded by the Xenopus Xenf gene (Nakatani et al., 2000) . The similarity between Xmenf and Xenf is limited to the N-and C-termini, which have 65% and 36% identity, respectively (Fig. 2B ).
Xmenf protein is localized in the nucleus
As was found with Xenf (Nakatani et al., 2000) , the predicted Xmenf amino acid sequence has no known protein motifs, providing no clues regarding the possible cellular activity of Xmenf. While the sequences of Xenf and Xmenf are highly divergent, they are similar enough that we propose they make up a new gene family. To investigate the subcellular localization of Xmenf protein, we made a fusion construct in which Xmenf was linked to GFP at its Nterminus. The fusion protein was found in the nucleus when detected with an anti-GFP antibody at the gastrula stage (Fig. 3A) , while GFP control was detected throughout the cell (Fig. 3B) . It was reported that Xenf is also nuclear localized (Nakatani et al., 2000) , suggesting that the two proteins might have a similar cellular activity. Whether Xmenf functions as a specific factor in transcriptional regulation or plays some other role in the nucleus remains to be determined.
The temporal and spatial expression of Xmenf mRNA
Expression of Xmenf was first detectable by northern blotting analysis at stage 9 (Fig. 4A ). It reached a peak at the early gastrula stage (stages 10-10.5), and transcripts were no longer detectable by the early neurula stage (stage 15), although very low expression was observed at stage 36. A number of genes expressed in the marginal zone show a very similar temporal expression pattern, including Xnr2, which is detected during late blastula (stage 9) and gastrula (stages 10 and 10.5) with a peak at stage 10 (Jones et al., 1995) .
The spatial expression of Xmenf was studied by in situ hybridization. Xmenf has a dynamic expression pattern in the marginal zone over the course of gastrulation. In addition to the marginal zone expression, a few scattered cells were observed to express Xmenf in the vegetal pole early in gastrulation (Fig. 4B ). At stages 10 and 10.25, Xmenf transcripts were observed in cells just above the blastopore lip in the Spemann organizer (right arrow in Fig. 4F ; lower arrow in Fig. 4C .). The Xmenf-expressing cells did not overlap with the Xenopus brachyury (Xbra)-expressing Xmenf is also expressed superficially in vegetal cells (B). At stage 10.25, the expression domains of Xmenf and Xbra are not only mutually exclusive, most obviously near the Spemann organizer (the bottom part of the embryo in C and the right part of the embryo in G), but also opposite from the Spemann organizer (the left part of the embryo in G). Although the expression domainsofthe geneslookasif theyoverlap insurface view(the toppartofthe embryoin C), the sectionshowsthat Xmenf isexpressedin cells in thesuperficiallayerof the animal marginal zone, while Xbra is expressed in cells in the deep layer (the left arrow and arrowhead in G). By stage 10.5, Xmenf is no longer expressed near the Spemann organizer, nor on the opposite side of the embryo in the superficial layer. At this stage, the expression domains of Xmenf and Xbra remain mutually exclusive in the marginal zone opposite from the Spemann organizer (the top part of the embryo in D and the left arrow and arrowhead in H). (E, I) Double in situ hybridization at stage 10.25-10.5 for Xmenf (black, arrows) and Xbra (red, arrowheads) in embryos that had been injected with XFD RNA in the marginal zone (B4 and C4 blastomeres at the 32-cell stage). The marginal zone on the injected side no longer expresses Xbra and shows very intense expression of Xmenf (arrow in E). The section in (I) reveals that Xmenf expression is expanded toward the region (arrow in I), where Xbra is normally expressed (arrowhead in H). cells of the animal marginal zone (arrow heads in Fig. 4G) . We have previously shown by following the fates of cells that had expressed Xbra in the gastrula embryo that Xbra is not a pan-mesodermal gene, but rather is expressed in presumptive dorsal mesodermal cells (Kumano et al., 2001) . Thus, the expression of Xmenf in the vegetal marginal zone is very similar to that of Xnr2 (Jones et al., 1995; Kumano and Smith, 2000) . By stage 10.5, Xmenf expression could no longer be detected around the Spemann organizer (Fig. 4H) . On the side of the embryo opposite the Spemann organizer, Xmenf is expressed at stage 10 in cells in the superficial layer of the marginal zone (left arrow in Fig. 4F ). By stage 10.5, Xmenf expression is no longer seen in superficial cells, but rather in deeper cells near the blastopore, again vegetal to the band of Xbra-expressing cells. Stage 10.25 shows an intermediate between these two expression patterns (Fig. 4G , left side). Xmenf expression is observed just above the blastopore lip (arrow in Fig. 4H ) and is distinct from the Xbra-expressing cells (arrow and top arrowhead in Fig. 4D , and arrow and left arrowhead in Fig. 4H ). The cells in the deep layer of the marginal zone between Xbra-expressing cells and the blastopore lip are the leading edge mesoderm and contribute to ventral mesoderm in the tailbud stage embryo (Keller, 1991; Kumano et al., 1999; Kumano and Smith, 2000; Lane and Smith, 1999) , while the cells in the superficial layer of the marginal zone become archenteron roof (Keller, 1975) .
Previous studies have shown that MAPK is not activated in the leading edge mesoderm (Christen and Slack, 1999; Curran and Grainger, 2000; Kumano et al., 2001 ) nor in the superficial layer (Schohl and Fagotto, 2002) , which correlates well with the observed expression pattern of Xmenf. In fact, Xmenf expression expanded into the animal marginal zone when FGF signaling was blocked by injecting XFD RNA (Fig. 4E, I , arrow). The expression of Xmenf in the leading edge mesoderm, but not in the superficial layer, appears to follow that of SMAD2 activation, a downstream component of activin/nodal signaling (Lee et al., 2001 ). Both SMAD2 activation in the whole of the marginal zone and Xmenf expression in leading edge mesoderm move as a wave across the marginal zone from the Spemann organizer. Thus, Xmenf expression appears to be restricted to those mesodermal cells that are positive for SMAD activation and negative for actMAPK.
Xmenf induction by nodals, activin
We observed that Xmenf was induced in Xenopus animal caps that had been injected with Xnr2 and XFD RNAs, but not with Xnr2 RNA alone (Fig. 5A) , consistent with the in situ results described above. Rehybridization of this blot with an eomes probe (pan-mesodermal) showed that equal amounts of mesoderm were induced by Xnr2 in the presence and in the absence of XFD (data not shown). We have previously reported that Xnr2 alone in animal caps induces expression of the dorsal mesoderm markers Xbra, XmyoD and the pan-mesodermal marker eomes, while the expression of Xbra and XmyoD, but not eomes, is greatly suppressed by coinjection of XFD RNA (Kumano et al., 2001 ). These expression patterns in the animal cap appear to reflect the endogenous expression patterns of Xbra and XmyoD in the animal marginal zone, Xmenf in the vegetal marginal zone/leading edge mesoderm, and eomes throughout the marginal zone .
Xnr2 is one of the six nodal-related genes known in Xenopus (Jones et al., 1995; Joseph and Melton, 1997; Takahashi et al., 2000) . Activin-like ligands, including Xnr1, 2, 4, 5, and 6, all have similar mesoderminducing activities in animal caps (Jones et al., 1995; Joseph and Melton, 1997; Takahashi et al., 2000) and are known to induce phosphorylation and activation of SMAD2 (Massague, 1998; Whitman, 2001; Whitman, 1998) . As such, the Xmenf-inducing activity is not unique to the combination of Xnr2 and XFD, and we observed that treatment of XFD RNA-injected animal caps with soluble recombinant activin induced Xmenf expression (Fig. 5B) . We used this same assay to determine if Xmenf induction by activin required protein synthesis. In cycloheximide-treated caps we observed an approximately 7.2-fold reduction in Xmenf transcript levels, whereas the level of eomes transcript in the same animal caps was unchanged. We conclude that at least a major component of Xmenf transcription requires protein synthesis, and that the residual Xmenf transcript in the cycloheximide-treated caps is either translation-independent, or the result of incomplete inhibition by cycloheximide.
Finally, we determined whether Xmenf is an in vivo downstream target of nodal signaling by using a dominant negative mutant of Xnr2 (CmXnr2; Osada and Wright, 1999) . CmXnr2 has been shown to act as a dominant negative ligand for Xnr1, 2, and 4, but not for activin and BVg1 . Injection of CmXnr2 RNA into one blastomere of the four-cell-stage embryo resulted in elimination of Xmenf expression in the descendants of the injected blastomere (Fig. 5C, arrowhead) . This result shows that endogenous nodal signaling is required for Xmenf expression in the gastrula embryo.
Xmenf potentiates globin induction by Xnr2
As Xmenf has no homology with any protein of known function, and has only limited similarity to the relatively uncharacterized protein Xenf, its role in normal development is not readily apparent. However, since Xmenf was isolated from animal caps that were in the early stages of being induced to ventral mesoderm by the combined action of Xnr2 and XFD, and since it is expressed endogenously in a group of cells that are fated to become ventral mesoderm, we speculate that Xmenf plays a role in the pathway of ventral mesoderm induction. The animal cap induction assay was used to investigate the activity of , muscle actin (somite), endodermin (edd, endoderm), and EF1a (loading control). The blot shows a modulation of the globin-inducing activity of Xnr2 in XFD coinjected animal caps. Whereas no globin was induced by 250 pg of Xnr2 and 400 pg of XFD RNA, the addition of Xmenf RNA gave strong globin induction (compare lanes 8 and 9), although at a higher dose of Xnr2 (500 pg) globin expression was reduced (lanes 10 and 11). In contrast, Xmenf did not alter the induction of muscle actin or edd by Xnr2 (compare lanes 7 and 9 to 5 and 8, respectively). (Hansen et al., 1997) , with or without 5 mg/ml of cycloheximide (CHX). Results of hybridization for Xmenf, eomes and EF1a (loading control) are shown. Induction of Xmenf expression by activin was significantly reduced in the presence of CHX (lane 5 compared to lane 4), while eomes expression was not affected by CHX as described previously . 'W' represents RNA from a whole embryo at stage 10 (lane 1). (C) In situ hybridization for Xmenf in embryos that had been injected with 500 pg of CmXnr2 RNA in one blastomere at the four-cell stage. Vegetal view with the Spemann organizer at the top. b-Gal staining in blue (arrowhead) is indicative of descendants of the injected cell. Xmenf expression is lost in descendants of the CmXnr2-injected blastomere (arrowhead).
Xmenf. We observed that Xmenf was able to potentiate the ventral-mesoderm-inducing activity of Xnr2/XFD (Fig. 6) . In the experiments shown in Fig. 6 , muscle actin was used as a marker of dorsal mesoderm, globin as a marker of ventral mesoderm, and endodermin (edd) was used as a marker of endoderm (Sasai et al., 1996) . The induction of globin by Xnr2 in XFD-coinjected animal caps shows a very sharp threshold. Whereas 250 pg of Xnr2 RNA gave no detectable globin transcript, strong induction was observed with 500 pg of Xnr2 RNA (Fig. 6, lanes 8 and  10) . However, we observed that coinjection of Xmenf RNA with 250 pg of Xnr2 resulted in a very strong induction of globin transcription (Fig. 6, lane 9) . When animal caps were examined at gastrula stage (stage 10), we observed a similar induction of eomes transcript by 250 pg Xnr2 and 400 pg XFD versus 250 pg Xnr2, 400 pg XFD and 1 ng Xmenf (data not shown). Thus, the action of Xmenf does not appear to change the overall quantity of mesoderm induced. In control experiments, we show that Xmenf alone, or a combination of any two of Xnr2, XFD or Xmenf RNAs did not result in globin induction (Fig. 6 , lanes 4 and 6-8). At the higher level of Xnr2 (500 pg), coinjection of Xmenf reduced the induction of globin relative to animal caps injected with only Xnr2 and XFD (Fig.  6, lanes 10 and 11) . Also, the higher amount of Xnr2 (500 pg) reduced the induction of globin relative to that by the lower amount of Xnr2 (250 pg) in the presence of Xmenf activity (Fig. 6 , lane 11 compared to lane 9). This reduction may be similar to that observed in Xbra expression induced by VegT or activin, where induction of Xbra expression declines with high concentrations of VegT or activin (Clements et al., 1999; Kavka and Green, 2000; Weber et al., 2000) . This alteration of Xnr2 inductive activity by Xmenf was specific to the pathway of ventral mesoderm induction (Xnr2 without FGF signaling). No change in either muscle actin or edd expression was observed in animal caps injected with the combination of Xnr2 and Xmenf versus those injected with Xnr2 alone (Fig. 6 , lanes 7 and 9 compared to lanes 5 and 8, respectively).
Discussion
Expression domains in gastrula marginal zone are defined by patterns of SMAD2 and actMAPK
In this study, we report the isolation of the nodal target gene Xmenf. Xmenf is strongly induced by nodal signals only when FGF signaling is blocked, and it appears to play a role in ventral mesoderm induction. Xmenf was isolated from Xnr2-induced animal caps, and the expression of endogenous Xmenf is blocked by dominant negative Xnr2. However, the endogenous nodal/activin-like signal that is responsible for Xmenf induction in the marginal zone is not necessarily Xnr2, as a number of nodals/activins are active in the blastula and gastrula embryo, and dominant negative Xnr2 inhibits the activity of a number of nodalrelated proteins . The expression of Xmenf closely parallels Xnr2 both spatially and temporally (Jones et al., 1995; Kumano and Smith, 2000) , so it is likely that some other activin/nodal signal preceding the onset of Xnr2 expression may be responsible for the activation of Xmenf expression. However, the coexpression of Xnr2 in the vegetal marginal zone with Xmenf may be responsible for maintaining Xmenf expression at the gastrula stage. In fact, nodal/activin signaling is essential for maintaining Xnr2 expression in the gastrula embryo through a positive feedback mechanism (Agius et al., 2000) , and Xnr5 and 6 are capable of inducing Xnr2 expression in animal caps (Takahashi et al., 2000) . Thus, we speculate that the expression of Xnr2 and Xmenf follows a parallel mechanism, both being dependent upon nodal/activin signaling and being inhibited by FGF signaling.
Most members of the nodal family of growth factors signal through a common pathway with other activin-like ligands (Massague, 1998; Whitman, 2001; Whitman, 1998) . The overlap of SMAD2 and actMAPK appears to define distinct gene induction domains in the marginal zone. The expression of some genes, including Xlim1, gsc, Xwnt8 and eomes is induced by activin irrespective of whether endogenous FGF signaling is inhibited or not (Cornell and Kimelman, 1994; Kumano et al., 2001) , whereas the induction of XmyoD and Xbra by activin-like signaling is completely inhibited by XFD (Cornell and Kimelman, 1994; Kumano et al., 2001; LaBonne and Whitman, 1994) . The expression of Xnr2 and Xmenf is induced by nodal signaling (Takahashi et al., 2000 ; this study) and enhanced by inhibition of FGF signaling (Kumano et al., 2001 ; this study). The endogenous expression patterns of these genes within the marginal zone appear to correspond with the spatial and temporal activation of SMAD2 and MAPK (Christen and Slack, 1999; Curran and Grainger, 2000; Kumano et al., 2001; Lee et al., 2001) . SMAD2 is activated in a broad region over the marginal zone and vegetal hemisphere, while MAPK is activated only in the animal marginal zone. Thus, XmyoD and Xbra are expressed in the midgastrula embryo where MAPK and SMAD2 activation overlap in the animal marginal zone, while Xnr2 and Xmenf are expressed in the vegetal marginal zone, which is positive for SMAD2 activation and negative for actMAPK. The pan-mesodermal gene eomes is expressed throughout the marginal zone. The endogenous actMAPK through FGF signaling in the marginal zone is essential for restricting the expression of genes to the vegetal marginal zone. The inhibition of endogenous FGF signaling in the animal marginal zone with XFD led to the expanded expression of both Xnr2 (Kumano and Smith, 2000) and Xmenf into the animal marginal zone, with a concomitant loss of XmyoD and Xbra expression (Kumano and Smith, 2000) at the gastrula stage, and to the expansion of globin expression and loss of somites at tailbud stage (Kumano and Smith, 2000) .
Xmenf and ventral mesoderm induction
Together, Xmenf and Xenf comprise a new family of nuclear proteins with no known functional motifs. Clearly, much remains to be determined about the molecular action of these two proteins. We subjected Xmenf to a number of assays to investigate its role in Xenopus development. We observed that injection of Xmenf RNA into whole embryos did not produce a detectable phenotype (data not shown). However, given that injected Xmenf RNA alone is neither able to induce endoderm-or mesoderm-specific gene expression in animal caps, nor able to modify the dorsal mesoderm-inducing activity of Xnr2 in animal caps, the lack of a phenotype in whole embryos is not surprising. We hypothesize that Xmenf is a nuclear factor that acts together with other gene products in the vegetal marginal zone in the early steps of ventral mesoderm development. This activity was evident when Xmenf was co-injected with a sub-inducing combination of Xnr2 and XFD RNAs. In this case, the co-injection of Xmenf gave a strong induction of globin expression. It is likely that Xnr2 and Xmenf are only two of a number of genes which are specifically expressed in the vegetal marginal zone and which are involved in the development of ventral mesoderm.
Patterning the animal-vegetal axis of the gastrula marginal zone
The current results allow us to expand upon an emerging model of patterning the marginal zone in the animal/vegetal axis (Fig. 7) . Induction and patterning in this axis is perpendicular to that resulting from the Spemann organizer activity, and appears to be independent of the Spemann organizer (Kumano and Smith, 2000) . Zygotic nodal-like signaling which is the downstream product of maternal VegT is essential for mesoderm induction (Clements et al., 1999; Kofron et al., 1999) , while FGF signaling appears to act as a competence/modifying factor. We have observed that inhibition of FGF signaling in the early Xenopus embryo with XFD results in the transformation of dorsally fated mesoderm (somite) to ventrally fated mesoderm (ventral blood island), rather than eliminating mesoderm induction as had been reported previously (Cornell et al., 1995) . Thus, FGF signaling in the marginal zone defines how cells respond to mesoderm inducers. We have included in our model a maternal FGF molecule that is localized to the animal hemisphere, and which leads to greater activation of MAPK in the animal hemisphere. The possibility of polarized maternal actMAPK in the animal/vegetal axis is somewhat unresolved. One group reports higher actMAPK and nuclear localization in the animal hemisphere and marginal zone of morula and blastula embryos using an antibody to phosphorylated MAPK. This enrichment in the animal hemisphere was observed by both in whole-mount staining and western blot (Curran and Grainger, 2000) . However, the opposite result (enrichment of FGF signaling in the vegetal pole prior to MBT) (Christen and Slack, 1999; LaBonne and Whitman, 1997) , as well as a more complex pattern in the pre-MBT embryo with little animal/vegetal enrichment (Schohl and Fagotto, 2002) have been reported. Yet, there is a general agreement that by gastrula stages MAPK is strongly activated in the marginal zone, presumably the downstream result of the expression of a number of FGF molecules in the animal marginal zone, including eFGF, FGF3 and FGF8 (Christen and Slack, 1997; Isaacs et al., 1995; Lombardo et al., 1998) . The end result is to define two domains in the marginal zone, an animal territory that expresses Xbra and other genes, and a vegetal domain that expresses Xnr2 and Xmenf.
There are several possible molecular mechanisms of how FGF signaling could alter the competence of cells to respond to activin-like signals. Most simply, one could ask whether the primary inducing factor and the competence factor act simultaneously or sequentially. An example of simultaneous action appears to operate in regulating gene expression in the Spemann organizer. Downstream components of the Wnt signaling cascade, b-catenin and Lef1/Tcf, form a complex with an essential mediator of TGF-b signal- ing, SMAD4, to activate expression of the twin gene during the formation of the Spemann organizer (Nishita et al., 2000) . This partly explains how the maternally localized Wnt signaling creates competence for TGF-b signaling to induce the Spemann organizer. The second possible mechanism of cell competence is that the first competence signal induces factors, such as transcription factors, that mark the competent state. For example, in chick neural induction, the first inductive signal, FGF, sensitizes the epiblast to BMP antagonists (the second inductive signal), and induces both ERN1 (Streit et al., 2000) and the transcription factor Sox3 (Streit and Stern, 1999) before the second signal is produced. In another example, the specification of the pericardial cells in Drosophila, the bHLH factor lethal-of-scute (l'sc) is induced by Wg and Dpp (the first inductive signals), and the second inductive signal through receptor tyrosine kinases stabilizes l'sc expression and leads to the expression of pericardiac cell-specific evenskipped (Carmena et al., 1998) . How FGF signaling in the marginal zone fits with these two models of competence is not clear, since there is both maternal FGF activity in the embryo (Cornell et al., 1995; Curran and Grainger, 2000) , and zygotic expression of FGFs in the animal marginal zone (Christen and Slack, 1997; Isaacs et al., 1995; Lombardo et al., 1998) (Fig. 7) . It is perhaps most likely that maternal FGF signaling precedes nodal signaling to establish a rudimentary pattern of mesoderm patterning, followed by simultaneous nodal and FGF signaling in the marginal zone to reinforce the pattern.
Experimental procedures
Xenopus embryos
Ovulation was induced by injecting female Xenopus with human chorionic gonadotropin (Sigma) and eggs were fertilized as described previously (Condie and Harland, 1987) . Eggs were dejellied 20 min after fertilization in 2% cysteine-HCl (pH 8.0), and were cultured in 1/3 MMR until ready for injection and RNA extraction. For 32-cellstage injection, fertilized eggs were cultured in 1/10 £ MMR until the 8-cell stage before being dejellied. Embryos were staged according to Nieuwkoop and Faber (1994) . Xenopus embryos were injected in the animal pole at the two-cell-stage with either 200 pg of XFD RNA plus 500 pg of Xnr2 RNA, or with 1 ng of a frame-shifted Xnr2 ( fsXnr2) RNA plus 400 pg XFD RNA. Two pools of 500 animal caps each were dissected in 3/4 NAM [82.5 mM NaCl, 1.5 mM KCl, 0.75 mM Ca(NO 3 ) 2 , 0.75 mM MgSO 4 , 75 mM EDTA, 1.5 mM sodium phosphate (pH 7.5)] with 25 mg/ml gentamycin and 1 mg/ml BSA at stage 8-9 from embryos that had been injected with the two RNA mixtures. The dissected animal caps were cultured in 3/4 NAM with gentamycin/ BSA until intact embryos reached stage 10.5 when total RNA was extracted. Poly(A) 1 RNA was prepared from the total RNAs used for subtraction with the PCR-Select cDNA Subtraction Kit (CLONTECH), which makes use of the technique of suppression PCR (Hubank and Schatz, 1994) . Subtracted fragments were cloned into pCR II vector using the TA Cloning Kit (Invitrogen) to make a subtracted library. Of the 204 clones tested from the subtracted library, one 710 bp clone (clone 157) was found to be differentially expressed (Fig. 1B) . To construct the frame-shifted Xnr2, a plasmid containing 1.4 kb of Xnr2 cDNA (Jones et al., 1995) was linearized with ClaI (a ClaI site is located at 307 bp downstream from the translation start site, ATG). After filling the recessed 5 0 termini with T4 DNA polymerase, the linearized plasmid was self-ligated. Sequencing confirmed that there were two additional nucleotides, CG, inserted in the Cla I site. A green fluorescent protein (GFP)-tagged version of Xmenf was made by fusing the GFP reading frame to the carboxyl-terminus of Xmenf. For this construct, the Xmenf coding region was amplified using the KpnI-containing oligonucleotide described above and 5 0 -TCCGGAGCTC-GTTGGTCTTCCATGCATGGCCTTCGA-3 0 , which added a SacI site immediately after the ACC that encodes the C-terminal amino acid of the protein. The GFP coding region was amplified from the plasmid GFP.RN3 (Zernicka-Goetz et al., 1996) using the T7-promoter primer and the oligonucleotide (5 0 -CACAGAGCTCATGAG-TAAAGGAGAAGAACTTTTCACTGG-3 0 ) which adds an SacI site immediately before the translational start site. The amplified GFP and Xmenf fragments were digested with SacI/PstI and KpnI/SacI, respectively, and then ligated into the KpnI and PstI sites of pSP64T3. The resulting construct has additional Glu-Leu residues inserted between the Xmenf and GFP coding regions. Plasmids for in vitro RNA synthesis were linearized with EcoRI for dominant negative FGF receptor (XFD; Amaya et al., 1991) , with Asp718 for dominant negative Xnr2 (CmXnr2; Osada and Wright, 1999) , with XhoI for Xnr2 and the frame-shifted Xnr2, and XbaI for Xmenf and the Xmenf-GFP fusion construct. Capped RNAs were transcribed with mMessage mMachine (Ambion). Embryos were injected by air pressure in 1/3 £ MMR/2.5% ficoll/ 25 mg/ml gentamycin. For animal cap assays, 10 nl containing various combinations of Xnr2 (0, 125, 250 or 500 pg), XFD (0 or 200 pg) and Xmenf (0 or 500 pg) RNAs were injected into the animal region of both blastomeres at the two-cell stage. CmXnr2 RNA (5 nl containing 500 pg) was injected into the vegetal region of one blastomere at the four-cell stage. Also, 1 nl containing 200 pg of XFD RNA was injected in both the B4 and C4 blastomeres at the 32-cell stage. Finally, 5 nl containing RNA encoding the Xmenf-GFP fusion protein was injected into the marginal zone of all the blastomeres at the two-cell stage.
RNA extraction and northern blotting
Animal caps for northern blotting were dissected and cultured as described above for subtraction cloning. At the equivalent of stage 10.5 or 32, total RNA was isolated using Trizol Reagent (Gibco). For analysis of temporal expression of Xmenf, total RNA was isolated from embryos of various stages. Northern analysis was performed as described previously (Kumano et al., 2001) . Probes were prepared with isolated fragments from eomesodermin (eomes; ), aT3 globin (Banville and Williams, 1985) , muscle actin (Dworkin-Rastl et al., 1986) , endodermin (edd; (Sasai et al., 1996) ), and EF1a (Krieg et al., 1989) . A probe for Xmenf was prepared by digesting the pCR II plasmid containing the 710 bp RsaI fragment with EcoRI.
4.5. b -Galactosidase staining, in situ hybridization and immunohistochemistry b-Galactosidase staining was done as described previously (Kumano et al., 1999) . Detection of Xmenf expression by in situ hybridization was performed as described previously (Harland, 1991) . A plasmid containing the 2.1 kb Xmenf cDNA fragment was linearized with XbaI and an antisense probe was synthesized with T7 polymerase. Double in situ hybridization was performed as described previously (Kumano and Smith, 2000) with the exception that a DIG-labeled Xmenf probe was used together with a fluorescein-labeled Xbra probe. In this case, Xbra transcripts were visualized in red, while Xmenf transcripts were visualized in black. Immunohistochemical staining for GFP was performed as described previously (Kumano et al., 2001) with the exception that an antibody to GFP (1/1,000; Santa Cruz Biotechnology) was used as a primary antibody and that the acetylation step was omitted.
Protein synthesis inhibition
Protein synthesis inhibition experiments were performed as described by Smith et al. (1991) with the exception that cycloheximide was applied continuously through the equivalent of stage 10.
